BIOS

Oct 13 2020 45 mins 2

The BIOS Podcast by Alix Ventures features experts and thought leaders in healthcare & life sciences. We bring you cutting-edge insights from executives, investors, founders, scientists, academics, and more. BIOS is a community of early stage healthcare and life sciences founders and investors. It is anchored by Alix Ventures, a San Francisco-based venture fund that invests in early stage healthcare and life sciences companies. Learn more at BIOS.community and Alix.vc




















All Things Biopharma: Rob Chess - Serial Entrepreneur & Executive
Mar 30 2020 51 mins  
Guest: Rob Chess Hosts: Jimmy Qian (@JimmyJQian), Kamal Obbad (@ObbadKamal) The biopharma industry is undergoing immense change as there are exciting advancements in technology and life sciences, amidst a constantly changing structural environment. Rob Chess discusses keys for success for founders and executives and explores some key trends involving scale, platforms, financing, discovery, and payment reform within biopharma. Rob Chess is a successful and esteemed serial biotech entrepreneur and executive. His resume is incredibly long and impressive. He is the Chairman of Nektar Therapeutics (NASDAQ: NKTR), a multi-billion dollar market cap company, where he was previously President and CEO. He is co-founder and Board member (until very recently the Chairman) of Biota Technologies, which uses DNA sequencing to optimize oil and gas production. He is a Lead Director at Twist Biosciences (NASDAQ: TWST), a public company that produces synthetic genes using an innovative high-throughput silicon-based manufacturing process. He was previously Chairman and CEO of OPX Biotechnologies, a renewable chemicals company that was sold to Cargill, and co-founder and President of Penederm, a dermatology company that went public and was acquired by Mylan Laboratories. He served in the White House in the first Bush administration, teaches at the Stanford business school, and is on the board of trustees at Caltech, and sits on the board of various other companies and organizations, among many other accomplishments. Topics: - Keys to success as a founder or executive in biotech - The cyclical nature of platforms, products, and financing in biotech as an industry - Scale in biopharma - The impact of tech-enabled services on biopharma and direct-to-consumer biopharma - Eroom’s law and drug discovery - Academia vs industry for life sciences innovation - Business model problems that belie the lack of successes in diagnostics - Incentive structures in healthcare and how to align them - Business school and management in healthcare and biopharma - Payment reform for specialty pharmaceuticals - Why go into healthcare? Thank you for listening! BIOS (@BIOS_community) is a community of early stage healthcare and life sciences founders and investors. Alix Ventures (@AlixVentures) is a SF-based venture fund that invests in early stage healthcare and life sciences companies. Music attribution: Danger Storm by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/4985-danger-storm License: http://creativecommons.org/licenses/by/4.0/




No review available yet...